dr. K.J.D. Kol

No picture available
E-mail:
k.j.d.kol umcg.nl

Research

Publications
  1. Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

    Merkus-Brunekreeft, K., Paijens, S., Wouters, M., Komdeur, F., Eggink, F., Lubbers-Marsman, J., Workel, H., Slikke, van der, E. C., Propper, N. E. J., Leffers, N., Adam, J., Pijper, H., Plat, A., Kol, A., Nijman, H. & Bruyn, de, M., 13-May-2020, In : OncoImmunology. 9, 1, p. 1-12 12 p., 1760705.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells

    Stutvoet, T. S., Kol, A., de Vries, E. G. E., de Bruyn, M., Fehrmann, R. S. N., van Scheltinga, A. G. T. T. & de Jong, S., Sep-2019, In : JOURNAL OF PATHOLOGY. 249, 1, p. 52-64 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. MAPK pathway activity plays a key role in programmed death ligand-1 expression of EGFR wild-type non-small cell lung adenocarcinoma cells

    Stutvoet, T., Kol, A., de Vries, E., de Bruyn, M., Fehrmann, R., van Scheltinga, A. T. & de Jong, S., Nov-2018, p. E78-E79. 2 p.

    Research output: Contribution to conferencePosterAcademic

View all (13) »

ID: 378071